Evidence map›Paper›PMID 24677539›Full record

ArticleBlood2014

Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder.

Ansuman T Satpathy, Carlos G Briseño, Xiongwei Cai, Drew G Michael, Chun Chou, Sunnie Hsiung, Deepta Bhattacharya, Nancy A Speck, Takeshi Egawa

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. C/EBPα activatesScience immunology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. The Biology of Dendritic Cells: In Health and Disease.Advances in experimental medicine and biology · 2025
    Review
  8. Article
  9. Article
  10. Chromatin structure undergoes global and local reorganization during murine dendritic cell development and activation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ansuman T SatpathyDepartment of Pathology and Immunology, School of Medicine, Washington University in St. Louis, St. Louis, MO; and.
Carlos G Briseño
Xiongwei Cai
Drew G Michael
Chun Chou
Sunnie Hsiung
Deepta Bhattacharya
Nancy A Speck
Takeshi Egawa
Washington University in St. Louis · USCancer Research Institute · USUniversity of Pennsylvania · US

Funding

Biochemistry of Leukemia Virus Core-Binding FactorR01HL091724 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SPECK, NANCY · 2008 to 2024
$8.3M
GENE REGULATION GOVERNING T LYMPHOCYTE FATE DECISIONSR01AI097244 · NIAID · WASHINGTON UNIVERSITY · PI EGAWA, TAKESHI · 2012 to 2016
$1.9M
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1R01CA149976 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SPECK, NANCY · 2011 to 2015
$1.6M
Functional and Anatomical Characterization of the Hematopoietic Stem Cell NicheK01DK078318 · NIDDK · WASHINGTON UNIVERSITY · PI BHATTACHARYA, DEEPTA · 2007 to 2011
$714k
NCI NIH HHS R01 CA149976NCI NIH HHS R01CA149976NHLBI NIH HHS R01 HL091724NIAID NIH HHS R01 AI097244NIAID NIH HHS R01AI097244NIDDK NIH HHS K01 DK078318NIDDK NIH HHS K01DK078318
6 · The paper itself

Abstract

Runx1 and Cbfβ are critical for the establishment of definitive hematopoiesis and are implicated in leukemic transformation. Despite the absolute requirements for these factors in the development of hematopoietic stem cells and lymphocytes, their roles in the development of bone marrow progenitor subsets have not been defined. Here, we demonstrate that Cbfβ is essential for the development of Flt3(+) macrophage-dendritic cell (DC) progenitors in the bone marrow and all DC subsets in the periphery. Besides the loss of DC progenitors, pan-hematopoietic Cbfb-deficient mice also lack CD105(+) erythroid progenitors, leading to severe anemia at 3 to 4 months of age. Instead, Cbfb deficiency results in aberrant progenitor differentiation toward granulocyte-macrophage progenitors (GMPs), resulting in a myeloproliferative phenotype with accumulation of GMPs in the periphery and cellular infiltration of the liver. Expression of the transcription factor Irf8 is severely reduced in Cbfb-deficient progenitors, and overexpression of Irf8 restors DC differentiation. These results demonstrate that Runx proteins and Cbfβ restrict granulocyte lineage commitment to facilitate multilineage hematopoietic differentiation and thus identify their novel tumor suppressor function in myeloid leukemia.

Indexed as

AnemiaAnimalsBone Marrow CellsCell DifferentiationCells, CulturedCore Binding Factor Alpha 1 SubunitCore Binding Factor Alpha 2 SubunitCore Binding Factor Alpha 3 SubunitCore Binding Factor beta SubunitDendritic CellsFlow Cytometryfms-Like Tyrosine Kinase 3Gene ExpressionGranulocytesHematopoiesisInterferon Regulatory Factor-8Cbfb protein, mouseCore Binding Factor Alpha 1 SubunitCore Binding Factor Alpha 2 SubunitCore Binding Factor Alpha 3 SubunitCore Binding Factor beta SubunitFlt3 protein, mousefms-Like Tyrosine Kinase 3Interferon Regulatory Factor-8Interferon Regulatory FactorsRunx1 protein, mouseRunx2 protein, mouseRunx3 protein, mouse

Identifiers

PMID24677539
PMCPMC4014839
OpenAlexW2058641251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.